View More Recent Stories

Mar 15, 2022 07:00AM Cogent Biosciences Provides Corporate Updates, Fourth Quarter and Full Year 2021 Financial Results
Mar 8, 2022 05:10PM Cogent Biosciences Announces Upcoming Presentations at AACR Annual Meeting 2022
Jan 5, 2022 07:02AM Cogent Biosciences (COGT) Issues 2022 Guidance
Jan 5, 2022 07:00AM Cogent Biosciences Provides 2022 Corporate Guidance
Nov 22, 2021 07:00AM Cogent Biosciences to Present at Piper Sandler 33rd Annual Virtual Healthcare Conference
Nov 10, 2021 07:00AM Cogent Biosciences Provides Corporate Updates and Reports Third Quarter 2021 Financial Results
Nov 2, 2021 07:00AM Cogent Biosciences to Present Virtually at Jefferies London Healthcare Conference 2021
Oct 7, 2021 09:00AM Cogent Biosciences Presents New Preclinical Data Demonstrating Bezuclastinib as a Differentiated KIT Inhibitor with Minimal Brain Penetration
Oct 1, 2021 07:00AM Cogent Biosciences to Present Preclinical Data on Bezuclastinib at AACR-NCI-EORTC Conference
Aug 16, 2021 07:00AM Cogent Biosciences Provides Corporate Updates and Reports Second Quarter 2021 Financial Results
Jul 27, 2021 07:00AM Cogent Biosciences to Present at Wedbush PacGrow Virtual Healthcare Conference 2021
Jun 29, 2021 07:00AM Cogent Biosciences to Present at Ladenburg Thalmann Virtual Healthcare Conference 2021
May 26, 2021 07:00AM Cogent Biosciences to Present at Jefferies Virtual Healthcare Conference 2021
May 12, 2021 07:00AM Cogent Biosciences Provides Corporate Updates and Reports First Quarter 2021 Financial Results
May 3, 2021 07:00AM Cogent Biosciences Appoints Evan Kearns as Chief Legal Officer
Apr 6, 2021 07:00AM Cogent Biosciences Announces Creation of Cogent Research Team
Mar 16, 2021 07:00AM Cogent Biosciences Reports Fourth Quarter 2020 and Full Year 2020 Financial Results
Feb 22, 2021 07:00AM Cogent Biosciences Appoints Accomplished Finance Executive Todd E. Shegog to its Board of Directors
Feb 18, 2021 07:00AM Cogent Biosciences to Present at Virtual 10th Annual SVB Leerlink Global Healthcare Conference 2021
Feb 11, 2021 07:00AM Cogent Biosciences to Present at LifeSci Partners Virtual Precision Oncology Day 2021
Dec 4, 2020 05:16PM Cogent Biosciences Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriter's Option to Purchase Additional Shares
Nov 30, 2020 07:00AM Cogent Biosciences Appoints Brad Barnett as Chief Technology Officer
Nov 20, 2020 07:00AM Cogent Biosciences to Participate in 3rd Annual Evercore ISI HealthCONx Virtual Conference
Nov 19, 2020 06:38AM Cogent Biosciences (COGT) Reports Final Results from PLX9486 Phase 1/2 Study in Advanced GIST Patients
Nov 18, 2020 09:00AM Cogent Biosciences Announces Final Results from PLX9486 Phase 1/2 Study in Advanced GIST Patients at CTOS 2020
Nov 12, 2020 04:30PM Cogent Biosciences to Present at Jefferies 2020 Virtual London Healthcare Conference
Nov 9, 2020 07:00AM Cogent Biosciences Reports Third Quarter 2020 Financial Results and Provides Corporate Updates
Nov 5, 2020 07:00AM Cogent Biosciences to Present at Piper Sandler 32nd Annual Virtual Healthcare Conference
Oct 26, 2020 07:03AM Cogent Biosciences (COGT) Appoints Andrew Robbins as CEO
Oct 26, 2020 07:00AM Cogent Biosciences Appoints Andrew Robbins as Chief Executive Officer
Sep 23, 2016 10:00AM Cogint, Inc. (Nasdaq: COGT) to Ring The Nasdaq Stock Market Opening Bell on Monday, September 26, 2016
View More Recent Stories